FDA Inspection
Medtronic IncMedtronic Inc – FDA Inspection, May 14, 2013
Record Details
This FDA Inspection record concerns Medtronic Inc, with an inspection on May 14, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Medtronic Inc
- Inspection Date
- May 14, 2013
- Product Type
- Biologics
View Company Profile
ID · 9998961b-eef0-4d20-91ac-8537afb963c1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 833131
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.265(f)Return to inventory--procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Medtronic Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 14, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 30, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 10, 2009 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Medtronic Inc
- FDA Inspection 982761 - 2016-07-14
- FDA Inspection 703615 - 2010-12-30
- FDA Inspection 595880 - 2009-07-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.